Tumor-associated stromal gene expression signatures predict therapeutic response to erlotinib/bevacizumab in non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Franzini, Anca
Durr, Oliver
Baty, Florent
Brutsche, Martin
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2014年 / 44卷
关键词：
Epithelial cell; Genetics; Cell biology;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P821
引用
收藏
页数：4
相关论文
共 50 条
  • [11] A randomized phase II trial of erlotinib or erlotinib and bevacizumab in patients with advanced EGFR mutant non-small cell lung cancer (NSCLC)
    Stinchcombe, T. E.
    Janne, P. A.
    Wang, X.
    Bertino, E. M.
    Weiss, J. M.
    Bazhenova, L.
    Gu, L.
    Lau, C. J.
    Paweletz, C. P.
    Jaslowski, A. J.
    Gerstner, G. J.
    Baggstrom, M. Q.
    Graziano, S. L.
    Beardenlii, J.
    Vokes, E. E.
    ANNALS OF ONCOLOGY, 2018, 29 : 522 - 522
  • [12] Stromal compartment specific gene signatures dissect immunotherapy response groups in non-small cell lung cancer
    Kulasinghe, A.
    Monkman, J.
    O'Byrne, K. J.
    ANNALS OF ONCOLOGY, 2021, 32 : S1380 - S1380
  • [13] A tumor-associated autoantibody panel for the detection of non-small cell lung cancer
    Cai, Ruijun
    Zhao, Feng
    Zhou, Haiying
    Wang, Zengsong
    Lin, Dang
    Huang, Lu
    Xie, Wenling
    Chen, Jiawen
    Zhou, Lamei
    Zhang, Ni
    Huang, Chaoyuan
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [14] Erlotinib: a new therapeutic approach for non-small cell lung cancer
    Bonomi, P
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (08) : 1395 - 1401
  • [15] EFFECT OF ERLOTINIB COMBINED WITH BEVACIZUMAB ON IMMUNE RESPONSE AND SERUM TUMOR MARKERS IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Wang, Jiang
    Xiong, Chunyan
    ACTA MEDICA MEDITERRANEA, 2023, 39 (01): : 169 - 173
  • [16] EGFR Exon-Level Biomarkers of the Response to Bevacizumab/Erlotinib in Non-Small Cell Lung Cancer
    Baty, Florent
    Rothschild, Sacha
    Frueh, Martin
    Betticher, Daniel
    Droege, Cornelia
    Cathomas, Richard
    Rauch, Daniel
    Gautschi, Oliver
    Bubendorf, Lukas
    Crowe, Susanne
    Zappa, Francesco
    Pless, Miklos
    Brutsche, Martin
    PLOS ONE, 2013, 8 (09):
  • [17] Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stromal
    Koukourakis, MI
    Giatromanolaki, A
    Sivridis, E
    Gatter, KC
    Harris, AL
    NEOPLASIA, 2005, 7 (01): : 1 - 6
  • [18] Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients
    Hwang, Ilseon
    Kim, Jeong Won
    Ylaya, Kris
    Chung, Eun Joo
    Kitano, Haruhisa
    Perry, Candice
    Hanaoka, Jun
    Fukuoka, Junya
    Chung, Joon-Yong
    Hewitt, Stephen M.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [19] Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients
    Ilseon Hwang
    Jeong Won Kim
    Kris Ylaya
    Eun Joo Chung
    Haruhisa Kitano
    Candice Perry
    Jun Hanaoka
    Junya Fukuoka
    Joon-Yong Chung
    Stephen M. Hewitt
    Journal of Translational Medicine, 18
  • [20] PTPRF expression as prognostic/predictive marker for treatment with erlotinib in non-small cell lung cancer (NSCLC)?
    Klughammer, Barbara
    Bordogna, Walter
    Delmar, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (30)
12345